碳氨酸对轻度至中度慢性阻塞性肺病患者恶化和肺功能的影响:多中心,双盲,随机,安慰剂控制的试验
Yumin Zhou1, Fan Wu2, Haiqing Li2
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China; Guangzhou National Laboratory, Bio-land, Guangzhou, China.
碳水化合物没有显著减少轻度至中度慢性阻塞性肺病 (COPD) 的恶化. 由于本试验的样本大小限制,无法充分评估肺功能功效.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 碳氨酸在治疗严重的COPD方面表现出潜力.
- 它在轻度至中度的COPD中的有效性需要进一步研究.
研究的目的:
- 为了评估碳水化合物对轻度至中度COPD患者恶化率和肺功能的影响.
主要方法:
- 第四期,双盲,随机,安慰剂对照试验.
- 539名患有轻度至中度慢性肺炎的患者在12个月内接受了碳水化合物或安慰剂.
- 副初级结果:每年恶化率和FEV1.1的变化.
主要成果:
- 碳水化合物组和安慰剂组之间每年恶化率没有显著差异 (0.39对0.46每患者年).
- 由于样本规模不足,肺功能 (FEV1) 变化没有得到充分评估.
- 招聘受到COVID-19大流行影响.
结论:
- 碳水化合物可能不会显著降低轻度至中度COPD的恶化.
- 结果可能会受到过高估计的疗效和基线失衡的影响.
- 肺功能功效仍然没有评估.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic...


